Form of Contingent Value Rights Agreement between Lantheus Holdings, Inc. and as Rights Agent Dated as of [●], 2020Contingent Value Rights Agreement • February 20th, 2020 • Lantheus Holdings, Inc. • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledFebruary 20th, 2020 Company Industry JurisdictionTHIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [•], 2020 (this “Agreement”), is entered into by and between Lantheus Holdings, Inc., a Delaware corporation (“Lantheus”), and [•], a [•] (the “Rights Agent”).